$0.04902
-0.02% - Trading Volume(24h) 89.35% $38,545,360.78
- Circulating Market Cap$86,761,337.63 #321
- FDV$162,772,196.4
- Circulating Supply1,769,745,956.34 BIO
- Total Supply3,320,000,000 BIO
- All-time High $0.8889 (Jan 03, 2025)
- All-time Low $0.04075 (Apr 16, 2025)
- Contract Address
- Supported Exchanges
- Launched Jan 2025
Performances
RD Popularity Index
107
4.9% (24h)
Project Rank: 214/19015
RD Growth Index
807
% (24h)
Project Rank: 221/19015
| 1h | 24h | 7d | 30d | 60d | 90d |
| 0.03% | 0.02% | 13.92% | 34.88% | 57.05% | 42.84% |
Comparison
Total Raised: --
Fundraising not disclosed
FDV: --
Token not listed
24h Trading Volume: --
Token not listed
Project Name
BIO Protocol
BIO
Intro
--
Total Raised
--
Core Team
--
Core Investors
--
RD Growth Index (7d %)

--
RD Popularity Index (7d %)
--
Details
BIO protocol is a financial layer for DeSci aimed at accelerating the flow of capital and talent into onchain science. bioDAOs can fundraise using the BIO protocol’s auction contracts and direct funding towards research initiatives, IP assets, and other biotech organizations.
Event Calendar
2024-08-20
BIO Protocol raised $ 6.22 M in Public Sale round
2024-11-08
BIO Protocol completed a strategic financing
2024-11-14
BIO Protocol raised $ 4.74 M in Public Sale round
2025-01-03
2025-01-03
2025-01-03
2025-09-17
BIO Protocol raised $ 6.9 M in Seed round
2026-03-31
Tokenomics
Top Holders
Open Markets
--
# | Exchange | Pair | Price | +2% depth | -2% depth | Volume (24h) | volume % |
|---|---|---|---|---|---|---|---|
No Data | |||||||
𝕏 Follow Updates
No Data𝕏 Follow Lists
$0.04902
-0.02% - Trading Volume(24h) 89.35% $38,545,360.78
- Circulating Market Cap$86,761,337.63 #321
- FDV$162,772,196.4
- Circulating Supply1,769,745,956.34 BIO
- Total Supply3,320,000,000 BIO
- All-time High $0.8889 (Jan 03, 2025)
- All-time Low $0.04075 (Apr 16, 2025)
- Total Raised $17.86M
- Contract Address
- Supported Exchanges
- Launched Jan 2025
Rate BIO Protocol
Rated by 0 users

What’s your take on BIO Protocol? Share your review.
Reviews and ratings are posted by users, do not constitute financial advice, and do not represent the views of the platform.








